Who
Yehia Hashad
EVP of R&D and CMO
Company insider
Files Form 4 as: EVP of R&D and CMO, Bausch + Lomb; Director, Unity Biotechnology; Director, Applied Genetic Technologies.
In numbers
- Trades disclosed
- 35
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 16 Aug 2021
- Last trade
- 5 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Aug 2026filed 7 Aug 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | —20,973 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | —20,973 at $0.00 | filing |
| 5 May 2026filed 7 May 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code F | $219K13,664 at $16.00 | filing |
| 5 May 2026filed 7 May 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code F | $219K13,664 at $16.00 | filing |
| 27 Feb 2026filed 2 Mar 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code F | $93K5,075 at $18.30 | filing |
| 27 Feb 2026filed 2 Mar 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code F | $213K11,621 at $18.30 | filing |
| 27 Feb 2026filed 2 Mar 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code F | $93K5,075 at $18.30 | filing |
| 27 Feb 2026filed 2 Mar 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code F | $213K11,621 at $18.30 | filing |
| 26 Feb 2026filed 2 Mar 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code F | $40K2,169 at $18.49 | filing |
| 26 Feb 2026filed 2 Mar 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code F | $40K2,169 at $18.49 | filing |
| 25 Feb 2026filed 27 Feb 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | —35,046 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | —35,046 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | —29,406 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | —29,406 at $0.00 | filing |
| 5 Aug 2025filed 7 Aug 2025 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | —17,715 at $0.00 | filing |
| 25 Jul 2025filed 28 Jul 2025 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code F | $41K2,841 at $14.32 | filing |
| 8 Mar 2025filed 10 Mar 2025 | Unity Biotechnologyoption or derivative | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 26 Feb 2025filed 28 Feb 2025 | BLCO Bausch + Lomboption or derivative · Medical Devices | SEC FORM 4 Code A | —60,085 at $0.00 | filing |
| 26 Feb 2025filed 28 Feb 2025 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | —25,225 at $0.00 | filing |
| 23 Dec 2024filed 26 Dec 2024 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code F | $41K2,324 at $17.83 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.